Catalyst Wire Dossier Catalyst Wire Dossier

Triamcinolone Acetonide Aqueous Nasal Spray

Triamcinolone acetonide · Apotex, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Triamcinolone Acetonide Aqueous Nasal Spray, covering 2009-09-30 to 2009-09-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing the Bioequivalence of Triamcinolone Acetonide Aqueous Nasal Spray (Apotex, Inc.) to That of Nasacort® AQ Nasal Spray (Sanofi-Aventis Pharmaceutical Products, Inc.) In the Treatment of Seasonal Allergic Rhinitis [Phase 3]

See pricing